miR‐203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver

Liver resection is still the most commonly used therapeutic treatment for hepatocellular carcinoma (HCC), and liver regeneration promotes HCC growth in the regenerating liver. The high recurrence/metastasis of HCC is the main cause of death for HCC patients after liver resection. However, how the au...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Sci
Päätekijät: Zheng, Xiao‐Bo, Chen, Xiao‐Bo, Xu, Liang‐Liang, Zhang, Ming, Feng, Lei, Yi, Peng‐Sheng, Tang, Jian‐Wei, Xu, Ming‐Qing
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2017
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378262/
https://ncbi.nlm.nih.gov/pubmed/28100026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13167
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia